Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04242797 · ClinicalTrials.gov registry record · NA
Central Mechanisms of Calmare: an fMRI Trial
A NA study, sponsored by Brigham Young University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04242797 is a NA study that has completed, run by Brigham Young University. The registered enrollment target is 39 participants.
The verdict
NCT04242797, a NA study, has completed, sponsored by Brigham Young University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Pilot one-treatment and extended 10-treatment studies are carried out on participants with peripheral neuropathy comparing traditional TENS and Calmare stimulation protocols using a double-blind apparatus. Resting fMRI scans are obtained before and after the treatment, as well as after most of the pain has returned.
Interventions
- DEVICE TENS
- DEVICE Calmare
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2017-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04242797
The ClinicalTrials.gov registry entry for NCT04242797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham Young University, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TENS is the first listed.
NCT04242797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04242797 about?
NCT04242797 is a clinical study titled "Central Mechanisms of Calmare: an fMRI Trial". Pilot one-treatment and extended 10-treatment studies are carried out on participants with peripheral neuropathy comparing traditional TENS and Calmare stimulation protocols using a double-blind apparatus. Resting fMRI scans are obtained before and after the treatment, as well as after most of the p...
What is the current status of trial NCT04242797?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2015-08-01. Estimated completion is 2017-11-15.
What interventions are being tested in trial NCT04242797?
The interventions under investigation include: TENS (DEVICE), Calmare (DEVICE).
Who is sponsoring clinical trial NCT04242797?
This trial is sponsored by Brigham Young University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.